Effect of botulinum toxin (BoNT-A) injections on intrinsic and reflexive contributions to ankle joint resistance for patients with spasticity

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON26235

Enrollment

Registered

2021-06-22

Start date

2020-08-07

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal Cord Injury and Stroke

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: - A minimum of 6 months post-lesion/post-stroke to ensure that the subject has a stable neurological condition, without clinical alterations. - Age 18 years or older at the time of the study - Spasticity of any/all of the m. triceps surae, i.e. have a MAS/Tardieu score = 1 - Have an ankle joint range of motion (ROM) of at least 20°in the sagittal plane - Ability to make a transfer on to the Achilles (medical device) - Current treatment of any/all of the m. triceps surae with BoNT-A for spasticity reduction

Exclusion criteria

Exclusion criteria: - Have a MAS score of 4 - Receive BoNT-A combined with other therapies aimed at reducing spasticity

Design outcomes

Primary

Measure	Time frame
Reflexive joint resistance (Nm/rad/s)	—

Secondary

Measure	Time frame
Intrinsic joint resistance (Nm/rad)	—

Contacts

Public ContactWieneke van Oorschot

Sint Maartenskliniek

w.vanoorschot@maartenskliniek.nl+31 24 365 2712

Outcome results